CGC_OUT_1 [2025-04-16 12:28:10 -0400] 4317 Bytes | 1133 tokens | Cum: 1133 tkns (14.16% of 8k)
==========================================================================

Alright, let’s light it up, because it's 12:28:09 PM on Wed Apr 16, 2025 -0400, and I'm charging into Canopy Growth (CGC), popping from 1.0100 to 1.2600. Is this our star stock of the day, or just a quick blip on the radar? I've got the scoop—time to analyze!

--- COMPANY PROFILE ---
Company: Canopy Growth (CGC)
IPO: 2014-04-07 (11 Years Ago)
Market Cap: $132,975,147
Shares Outstanding: 156,200,000
Industry: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Exchange: XNAS
Description: Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.

Here’s a list of headlines for Canopy Growth:

Apr-10-25 09:00AM - Here is What to Know Beyond Why Canopy Growth Corporation (CGC) is a Trending Stock
Apr-02-25 12:00PM - What Makes Canopy Growth (CGC) a New Buy Stock
Apr-02-25 12:00PM 07:30AM - Canopy Growth and Spectrum Therapeutics Announce Spectrum Reserve, A New Premium Medical Cannabis Brand
Apr-01-25 07:30AM - Canopy Growth Strengthens Balance Sheet with Optional Early Prepayment to Reduce Term Loan by US$100 Million
Mar-30-25 03:36AM - Cannabis Investors Should Sell Canopy Growth
Mar-27-25 09:03PM - Is Canopy Growth Corporation's (CGC) the Best Cannabis Stock to Buy According to Billionaires?
Mar-27-25 09:03PM 09:00AM - Is Trending Stock Canopy Growth Corporation (CGC) a Buy Now?
Mar-17-25 10:00AM - Wana Brands Brings Hemp-Derived THC Edibles to Texas

Here's another list of headlines with menu handles.
I will deliver the full text of the following stories when you say their handle.
Just say, for example, B1, B2, etc.

B1 - 2025-04-16T01:00:00Z - Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Viatris, Canopy Growth, and Everus and Encourages Investors to Contact the Firm
B2 - 2025-04-13T20:00:00Z - CGC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Canopy Growth Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
B3 - 2025-04-12T19:30:00Z - ROSEN, LEADING TRIAL ATTORNEYS, Encourages Canopy Growth Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - CGC
B4 - 2025-04-09T22:41:00Z - ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Canopy Growth Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - CGC
B5 - 2025-04-07T20:00:00Z - CGC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Canopy Growth Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
B6 - 2025-03-03T17:18:00Z - Canopy Growth’s stock falls to all-time low on pot company’s share-sale plans

==============
-> THE ROLE FOR AI:
==============

1) You are the **AI analyst-investigator**, and this interaction represents a full **due diligence session** for Canopy Growth (CGC).
Due diligence includes financial data, insider trading, relevant news, and any SEC filings — and may extend beyond classic fundamentals.
Your task is to identify whether this stock has momentum and potential.

2) I am **ScanScor**, a unified report generator that archives this session as part of our real-time diligence record.

3) You will request information by referencing documents by their code.

4) As the analysis proceeds, your are encouraged to review documents until you feel confident in your judgment.
After seeing 3 sets of news articles, SEC docs, and financials, you'll be prompted to return some data pairs.

5) News articles, SEC filings, and key metrics will be revealed in subsequent prompts.

Stay focused. Gather evidence. Continue until your conclusions are clear.
Restrict all your responses to just 3 tokens until the summary and data pairs at the end.

NEXT: Request a document with its reference code(s), such as:
- `B1`, `B2`, `B3`, etc.
- To load a new set of information and menu options, reply with: `NEX`

CGC_OUT_3 [2025-04-16 12:28:12 -0400] 962 Bytes | 271 tokens | Cum: 1406 tkns (17.57% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
**Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Viatris, Canopy Growth, and Everus and Encourages Investors to Contact the Firm**Date: Unknown DateSource: Unknown SourceURL: https://www.globenewswire.com/news-release/2025/04/16/3062226/0/en/Bragar-Eagel-Squire-P-C-Reminds-Investors-That-Class-Action-Lawsuits-Have-Been-Filed-Against-Viatris-Canopy-Growth-and-Everus-and-Encourages-Investors-to-Contact-the-Firm.htmlBragar Eagel & Squire, P.C. has filed class action lawsuits against Viatris, Canopy Growth, and Everus Construction Group, alleging various issues related to the companies' operations and financial reporting.

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

CGC_OUT_5 [2025-04-16 12:28:13 -0400] 1028 Bytes | 291 tokens | Cum: 1699 tkns (21.24% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-04-16T01:00:00Z - Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Via...
A2 - 2025-04-14T22:46:00Z - CGC Investors Have Opportunity to Lead Canopy Growth Corporation Securities Fraud Lawsuit...
A3 - 2025-04-14T16:18:00Z - Law Offices of Frank R. Cruz Encourages Canopy Growth Corporation (CGC) Investors To Inquire About S...
A4 - 2025-04-14T16:26:37Z - Law Offices of Frank R. Cruz Encourages Canopy Growth Corporation (CGC) Investors To Inquire About S...
A5 - 2025-04-14T16:04:41Z - Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Canopy Growth Corporatio...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

CGC_OUT_7 [2025-04-16 12:28:14 -0400] 1181 Bytes | 341 tokens | Cum: 2042 tkns (25.52% of 8k)
==========================================================================

Showing A1 (chunk 1 of 6): A1:
**Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Viatris, Canopy Growth, and Everus and Encourages Investors to Contact the Firm - Everus Construction Group (NYSE:ECG), Canopy Gwth (NASDAQ:CGC)**Date: 2025-04-16Source: {'uri': 'benzinga.com', 'dataType': 'news', 'title': 'Benzinga'}URL: https://www.benzinga.com/pressreleases/25/04/g44829932/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-viatrNEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Viatris Inc. VTRS, Canopy Growth Corporation CGC, and Everus Construction Group, Inc. ECG. Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additio

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

CGC_OUT_9 [2025-04-16 12:28:15 -0400] 1181 Bytes | 290 tokens | Cum: 2334 tkns (29.18% of 8k)
==========================================================================

Showing A1 (chunk 2 of 6): nal information about each case can be found at the link provided.

Viatris Inc. VTRS

Class Period: August 8, 2024 - February 26, 2025

Lead Plaintiff Deadline: June 3, 2025

The Complaint alleges that Defendants provided investors with material information concerning the failed inspection of Viatris' Indore, India facility. Specifically, the Complaint alleges that Defendants' statements misrepresented the FDA's issuance of a warning letter and its impact on Viatris' operations and that Defendants routinely referred to the impact of the warning letter as a mere "minor headwind" for the Company.

For more information on the Viatris class action go to: https://bespc.com/cases/VTRS

Canopy Growth Corporation CGC

Class Period: May 30, 2024 - February 6, 2025

Lead Plaintiff Deadline: June 3, 2025

According to the lawsuit, during the Class Period, defendants made false and/or misleading st

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

CGC_OUT_11 [2025-04-16 12:28:15 -0400] 1181 Bytes | 262 tokens | Cum: 2598 tkns (32.48% of 8k)
==========================================================================

Showing A1 (chunk 3 of 6): atements and/or failed to disclose that: (1) Canopy Growth had incurred significant costs producing Claybourne Co. ("Claybourne") pre-rolled joints in connection with the Claybourne product launch in Canada; (2) the foregoing costs, in addition to certain indirect costs that Canopy Growth incurred in connection with its Storz & Bickel vaporizer devices, were likely to have a significant negative impact on the Canopy Growth's gross margins and overall financial results; (3) accordingly, defendants had overstated the efficacy of Canopy Growth's cost reduction measures and the health of its gross margins while downplaying issues with the same; and (4) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

For more information on the Canopy Growth cla

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

CGC_OUT_13 [2025-04-16 12:28:16 -0400] 1181 Bytes | 274 tokens | Cum: 2874 tkns (35.93% of 8k)
==========================================================================

Showing A1 (chunk 4 of 6): ss action go to: https://bespc.com/cases/CGC

Everus Construction Group, Inc. ECG

Class Period: October 31, 2024 - February 11, 2025

Lead Plaintiff Deadline: June 3, 2025

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, the Complaint alleges that Defendants failed to disclose to investors that: (1) the Company's backlog conversion cycle had become elongated due to larger, more complex projects; (2) as a result, the Company's revenue recognition would be delayed; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

For more information on the Everus class action

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

CGC_OUT_15 [2025-04-16 12:28:19 -0400] 1104 Bytes | 319 tokens | Cum: 3195 tkns (39.94% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S4 - 2025-02-28 8-K Item 9.01 Fin Stmnts and Exhibits.

(d) Exhibits.

Exhibit Number Exhibit Description 1.1*+ Equity Distribution Agrmt, dated as of February 28, 2025, by and among Canopy Growth Corporation and BMO Capital Markets Corp. and BMO Nesbitt Burns Inc. 5.1 Opinion of Cass...

S6 - 2025-02-07 8-K Item 2.02 Results of Oper and Fin Cond.

On February 7, 2025, Canopy Growth Corporation issued a press release announcing its financial results for its fiscal third quarter ended December 31, 2024. A copy of the press release is attached hereto as Exhibit 99.1 a...

S7 - 2025-02-07 10-Q Item 1. Financi al Stmnts.

CANOPY GROWTH CORPORATION

COND INTERIM CO NSOLIDATED BAL SHEETS

(in thousands of Canadian dollars, except number of shares and per share data, unaudited)

December 31, 2024

March 31, 2024

ASSETS

Curr assets:

Cash and cash...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

CGC_OUT_17 [2025-04-16 12:28:20 -0400] 1027 Bytes | 265 tokens | Cum: 3462 tkns (43.28% of 8k)
==========================================================================

Showing S4 (chunk 1 of 1): S4:
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number Exhibit Description 1.1*+ Equity Distribution Agreement, dated as of February 28, 2025, by and among Canopy Growth Corporation and BMO Capital Markets Corp. and BMO Nesbitt Burns Inc. 5.1 Opinion of Cassels Brock Blackwell LLP 23.1 Consent of Cassels Brock Blackwell LLP (included in Exhibit 5.1) 104 Cover Page Interactive Data File (formatted in Inline XBRL document)

* A non-material exhibit has been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company hereby undertakes to furnish supplemental copies of the omitted exhibit upon request by the SEC.

+ Portions of this exhibit have been omitted pursuant to Item 601(a)(6) of Regulation S-K....

Respond with ONLY ONE of the following (3 characters max):
- `MOR` to continue this item
- `NEX` to move to the next set of documents
- `C2`, `S3`, etc. to request another document
**DO NOT SUMMARIZE. DO NOT EXPLAIN.** Wait until all data is presented.

CGC_OUT_19 [2025-04-16 12:28:29 -0400] 6449 Bytes | 1764 tokens | Cum: 5228 tkns (65.35% of 8k)
==========================================================================

This is our set of metrics for Canopy Growth.
Please analyze the numbers.

+-------------------+-----------------------+-------------------------+------------------------+
| Volume: 7,831,608 | Perf Month: 3.38% | Option/Short: Yes / Yes | Sales Y/Y TTM: -17.54% |
+-------------------+-----------------------+-------------------------+------------------------+
| Avg Volume: 7.53M | Perf Quarter: -45.27% | Short Float: 9.48% | ROE: -84.50% |
+-------------------+-----------------------+-------------------------+------------------------+
| Rel Volume: 2.34 | Index: - | Short Ratio: 1.94 | ROI: -46.51% |
+-------------------+-----------------------+-------------------------+------------------------+
| RSI (14): 56.42 | Market Cap: 187.28M | Short Interest: 14.59M | Sales Surprise: 6.22% |
+-------------------+-----------------------+-------------------------+------------------------+
| ATR (14): 0.12 | Shs Outstand: 154.83M | Beta: 0.81 | EPS Surprise: -133.08% |
+-------------------+-----------------------+-------------------------+------------------------+
| SMA20: 20.13% | Shs Float: 154.03M | Sales Q/Q: -7.25% | P/E: - |
+-------------------+-----------------------+-------------------------+------------------------+
| SMA50: -8.22% | Inst Own: 6.31% | Sales past 5Y: -3.56% | Earnings: Feb 07 BMO |
+-------------------+-----------------------+-------------------------+------------------------+
| SMA200: -68.11% | Insider Own: 0.51% | Employees: 1029 | |
+-------------------+-----------------------+-------------------------+------------------------+
| Perf Week: 34.68% | Insider Trans: -1.99% | Debt/Eq: 0.83 | |
+-------------------+-----------------------+-------------------------+------------------------+

The next section covers any insider trading by Canopy Growth officers or majority shareholders (if available).

Inside Trans: Canopy Growth Corp (CGC) by Kruh Willy (Unknown Title) on 2025-03-31
- Common Shares: 2012 shares at $0.92 (D)

Inside Trans: Canopy Growth Corp (CGC) by Lazzarato David Angelo (Unknown Title) on 2025-03-31
- Common Shares: 3004 shares at $0.92 (D)

Inside Trans: Canopy Growth Corp (CGC) by Yanofsky Theresa (Unknown Title) on 2025-03-31
- Common Shares: 2004 shares at $0.92 (D)

Inside Trans: Canopy Growth Corp (CGC) by Mongeau Luc (Chief Executive Officer) on 2025-02-11
- Common Shares: 50000 shares at $0 (D)
- Stock Option: 225000 shares at $0 (D)

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 276752000.0, 'unit': 'CAD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -469664000.0, 'unit': 'CAD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 1.265
Average Volume: 5949232.35
30-Day High: 1.265
30-Day Low: 0.8282

[Detailed Financials: Q3 2025]
- Total Assets: $1,164,219,000.0
- Total Liabilities: $572,744,000.0
- Total Equity: $591,475,000.0
- Current Assets: $341,085,000.0
- Current Liabilities: $97,016,000.0

[Income Statement: Q3 2025]
- Revenue: $74,761,000.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -1.11

[Cash Flow Statement: Q3 2025]
- Net Cash Flow: $-66,507,000.0

[Detailed Financials: Q2 2025]
- Total Assets: $1,232,348,000.0
- Total Liabilities: $722,680,000.0
- Total Equity: $509,668,000.0
- Current Assets: $391,665,000.0
- Current Liabilities: $281,284,000.0

[Income Statement: Q2 2025]
- Revenue: $62,991,000.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -1.48

[Cash Flow Statement: Q2 2025]
- Net Cash Flow: $36,260,000.0
==== END OF FINANCIAL REPORT ====

You are now requested to write a summary analysis of Canopy Growth (CGC).

Please complete the report using the exact format:
FIELD[value]

1) BRIEF_SUMMARY[]
One well-worded paragraph summarizing your findings about Canopy Growth.

2) MARKET_SCORE[]
This conversation was initiated because CGC is currently experiencing upward price and volume movement.
Estimate a number between 1–100 based on the likelihood of a continued upward price move for CGC.
Weigh relevant data — news, filings, fundamentals, and metrics — and assign appropriate weight.

3) PRICE_TARGET[]
Suggest a price, based on all prior evidence and past price behavior, CGC could reach in the current or upcoming trading sessions (1–5 days).
For example, if you expect CGC to increase 50% from its current price of $0.00, say: PRICE_TARGET[0.0]

4) AI_RPT_HEADLINE[]
Write a thought-provoking 8–12 word headline summarizing this report.

5) SQUEEZE_POTENTIAL[]
Give a score from 1 to 100 representing the potential for this stock to become an active short squeeze play.
Be honest and unbiased. Consider short interest/float, price movement, volume, news strength, and volatility potential.

6) TAGS[]
List 3–6 comma-separated tags (e.g., biotech, earnings beat, squeeze setup)

7) STOCK_TYPE[]
Choose the most accurate classification: growth, value, turnaround, hype, squeeze, dividend, speculative, or other.

8) PRIMARY_CATALYST[]
e.g., earnings report, FDA approval, partnership, etc.

9) SENTIMENT[]
bullish, bearish, neutral, or mixed

10) IMPROVEMENT_SUGGESTION[]
If you believe some key info was missing, state what would have significantly improved your analysis of Canopy Growth.

11) ETHICAL_RATING[]
Rate Canopy Growth’s alignment with long-term shareholder interests, using a letter grade from A (high alignment) to F (low alignment).
Base this on actions such as insider buying/selling, share dilution, follow-through on public statements, and compensation practices.

12) UPCOMING_CATALYST[]
Specify any upcoming events you expect would be a catalyst affecting the share-price of Canopy Growth.
Provide any reasons you can use to support it.

Return only: FIELD[value] for each of the above 12 questions.
Respond with all data pairs. Take your best guess if you have to, but don't leave blank items.
Do not explain your answers. Return only the required fields in the exact format shown.

Finally, thank you for participating!

CGC_IN_21 [2025-04-16 12:28:29 -0400] 126 Bytes | 29 tokens | Cum: 5482 tkns (68.53% of 8k)
==========================================================================

====================================
[2025-04-16 12:28:29] # Analysis Completed
Elapsed Time: 20.30 seconds